Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation (Q79919779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

title

Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

2

Youlia M Kirova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

Dominique Stoppa-Lyonnet

7

object named as

Dominique Stoppa-Lyonnet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

5

Bernard Asselain

1 reference

27 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

author name string

Fatima Laki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

Pascale This

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

Corinne Plancher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

Xavier Sastre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

Remy Salmon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

IC-BOCRSG IC-BOCRSG: Institut Curie - Breast Ovary Cancer Risk Study Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1784-1790

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

Cancer risks in BRCA2 mutation carriers

27 December 2019

cites work

1 reference

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

7 January 2021

Unusual case of Smith-Lemli-Opitz syndrome "type II"

1 reference

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

7 January 2021

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

7 January 2021

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

1 reference

7 January 2021

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

1 reference

7 January 2021

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

1 reference

7 January 2021

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

7 January 2021

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

1 reference

7 January 2021

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations

1 reference

7 January 2021

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

1 reference

7 January 2021

1 reference

7 January 2021

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group

1 reference

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

7 January 2021

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers

1 reference

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

7 January 2021

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations

1 reference

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

7 January 2021

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

1 reference

7 January 2021

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers

1 reference

7 January 2021

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

1 reference

7 January 2021

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

7 January 2021

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations

1 reference

7 January 2021

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

1 reference

7 January 2021

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy

1 reference

7 January 2021

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study

1 reference

7 January 2021

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

7 January 2021

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

1 reference

7 January 2021

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

1 reference

7 January 2021

Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers

1 reference

7 January 2021

Cancer Incidence in BRCA1 mutation carriers

1 reference

7 January 2021

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

1 reference

7 January 2021

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

1 reference

7 January 2021

Hormone replacement therapy after prophylactic adnexectomy

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNCR.22603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17351952 AND SRC:MED&resulttype=core&format=json

27 December 2019

1 reference